ArticleOman journal of ophthalmology
A comparative study of retinal vein occlusion and serum 25 hydroxy Vitamin D at a tertiary care centre.
Article in Oman journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- A comparative study of retinal vein occlusion and serum 25-hydroxy Vitamin D in a tertiary care hospital.Oman journal of ophthalmologyArticle
- Comment on a comparative study of retinal vein occlusion and serum 25-hydroxy Vitamin D at a tertiary care center.Oman journal of ophthalmologyArticle
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevalence of retinal vascular occlusion is second to diabetic retinopathy and age-related macular degeneration. Various age-related local and systemic factors have been associated with retinal vein occlusion (RVO). Hemodynamic changes (venous stasis), degenerative changes of the vessel wall and blood hypercoagulability underlies the pathogenesis. The role of Vitamin D in modulating the inflammatory responses within the arterial wall, the capacity to attenuate the oxidative stress and direct effect of hypovitaminosis D on increased vascular resistance hints at a potential association of Vitamin D levels with disorders of retinal vasculature.
aimTo estimate serum 25-hydroxyvitamin D (25 OH Vit D) level in patients of RVO and compare it with matched controls. MATERIALS AND
methodsFifty patients of RVO as cases and 50 without RVO as controls underwent systemic and ocular examination including the estimation of serum 25 OH Vit D and other biochemical parameters. STATISTICAL ANALYSIS: Statistical Package for the Social Sciences (SPSS) software version 25 was used for the analysis. An alpha level of 5% was taken, that is
resultsMean serum 25 OH Vit D level in cases of RVO was 21.82 nanogram/deciliters (ng/dL) compared to 30.71 ng/dL in the control group which was significantly lower in cases compared to control (
conclusionA positive association of low serum 25 OH Vit D levels and RVO was found highlighting the importance of evaluating serum Vitamin D levels in all the cases of RVO. This correlation may have possible implications for prophylaxis and treatment of RVO, even though this part of our country gets abundant sunlight throughout the year.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.